Respiratory Medicine
Volume 104, Issue 8 , Pages 1160-1170 , August 2010

Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ)

  • Nicola A. Hanania

      Affiliations

    • Pulmonary and Critical Care Medicine, Baylor College of Medicine, 1504 Taub Loop, Houston, TX 77030, Texas, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 7138733454; fax: +1 7138733346.
    • ,
  • David M. Mannino

      Affiliations

    • University of Kentucky School of Medicine, Lexington, KY, USA
    • ,
  • Barbara P. Yawn

      Affiliations

    • Olmsted Medical Center, Department of Research, Rochester, MN, USA
    • ,
  • Douglas W. Mapel

      Affiliations

    • Lovelace Clinic Foundation, Albuquerque, NM, USA
    • ,
  • Fernando J. Martinez

      Affiliations

    • University of Michigan Health System, Ann Arbor, MI, USA
    • ,
  • James F. Donohue

      Affiliations

    • University of North Carolina School of Medicine, Chapel Hill, NC, USA
    • ,
  • Mark Kosinski

      Affiliations

    • QualityMetric, Inc., Lincoln, RI, USA
    • ,
  • Regina Rendas-Baum

      Affiliations

    • QualityMetric, Inc., Lincoln, RI, USA
    • ,
  • Matthew Mintz

      Affiliations

    • George Washington University School of Medicine, Washington, DC, USA
    • ,
  • Steven Samuels

      Affiliations

    • Indiana Internal Medicine Consultants, Greenwood, IN, USA
    • ,
  • Priti Jhingran

      Affiliations

    • GlaxoSmithKline, Research Triangle Park, NC, USA
    • ,
  • Anand A. Dalal

      Affiliations

    • GlaxoSmithKline, Research Triangle Park, NC, USA

Received 21 December 2009 ,Accepted 10 February 2010.

References 

  1. Global initiative for chronic obstructive lung disease. Executive summary. National Institutes of Health: National Heart, Lung, and Blood Institute; 2008;Available at: http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=2003Updated
  2. Radin A, Cote C. Primary care of the patient with chronic obstructive pulmonary disease—part 1: frontline prevention and early diagnosis. Am J Med. 2008;121(Suppl. 7):S3–S12
  3. Celli BR. Chronic obstructive pulmonary disease: from unjustified nihilism to evidence-based optimism. Proc Am Thorac Soc. 2006;3:58–65
  4. Celli BR. Update on the management of COPD. Chest. 2008;133:1451–1462
  5. Cooper CB, Dransfield M. Primary care of the patient with chronic obstructive pulmonary disease—part 4: understanding the clinical manifestations of a progressive disease. Am J Med. 2008;121(Suppl. 7):S33–S45
  6. Godtfredsen NS, Lam TH, Hansel TT, et al. COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J. 2008;32:844–853
  7. Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007;356:775–789
  8. Ferguson GT, Anzueto A, Fei R, et al. Effect of fluticasone propionate/salmeterol (250/50 mcg) or salmeterol (50 mcg) on COPD exacerbations. Respir Med. 2008;102:1099–1108
  9. Anzueto A, Ferguson GT, Feldman G, et al. Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes. COPD. 2009;320–329
  10. Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate endpoints (ECLIPSE). Eur Respir J. 2008;31:869–873
  11. Lomas DA, Silverman EK, Edwards LD, et al. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort. Thorax. 2008;63:1058–1063
  12. Lomas DA, Silverman EK, Edwards LD, et al. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD. Eur Respir J. 2009 Jan 22;[Epub ahead of print]
  13. Decramer M, Celli B, Tashkin DP, et al. Clinical trial design consideration sin assessing long-term functional impacts of tiotropium in COPD: the UPLIFT trial. COPD. 2004;1:303–312
  14. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2000;160:1683–1689
  15. American Thoracic Society/European Respiratory Society Task Force . Standards for the diagnosis and management of patients with COPD [Internet]. Version 1.2. New York: American Thoracic Society; 2004;Available from: http://www.thoracic.org/go/copd[updated 2005 September 8]
  16. Yawn BP, Mapel DW, Mannino DM, et al. Development of the lung function questionnaire (LFQ) to identify airflow obstruction. Int J COPD. 2010;5:1–10
  17. DeLong ER, DeLong DM, Clarke Pearson DL. Comparing the areas under two or more correlated receiver-operating characteristic curves; a nonparametric approach. Biometrics. 1988;44:837–845
  18. Kerlinger FN. Foundations of behavioral research. New York: Holt, Rinehart and Winston; 1973;
  19. Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63:402–407
  20. Fromer L, Cooper CB. A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD. Int J Clin Pract. 2008;62:1219–1236
  21. Shahab L, Jarvis MJ, Britton J, et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61:1043–1047
  22. Ware JE, Kosinski M. SF-36 health survey (version 2.0) (Technical Note, September 20). Boston: Health Assessment Lab; 1996;
  23. Nathan RA, Sorkness CA, Kosinski M, et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol. 2004;113:59–65
  24. Schatz M, Sorkness CA, Li JT, et al. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117:549–556
  25. Calverly PMA, Nordyke RJ, Halbert RJ, et al. Development of a population-based screening questionnaire for COPD. COPD: J Chron Obstruct Pulmon Dis. 2005;2:225–232
  26. Martinez RJ, Raczek AE, Seifer FD, et al. Development and initial validation of a self-scored COPD population screener questionnaire (COPD-PS). COPD: J Chron Obstruct Pulmon Dis. 2008;5:85–95
  27. Buffels J, Degryse J, Heyrman J, et al. Office spirometry significantly improves early detection of COPD in general practice. The DIDASCO study. Chest. 2004;125:1394–1399
  28. Beeh KM, Kornmann O, Beier J, et al. Clinical application of a simple questionnaire for the differentiation of asthma and chronic obstructive pulmonary disease. Respir Med. 2004;98:591–597
  29. Price D, Tinkelman D, Nordyke R, et al. Scoring system and clinical application of COPD diagnostic questionnaires. Chest. 2006;129:1531–1539
  30. van Schayck C, Loozen J, Wagena E, et al. Detecting patients at high risk of developing chronic obstructive pulmonary disease in a general practice: cross sectional case finding study. BMJ. 2002;324:1370
  31. Mullerova H, Wedzicha J, Soriano J, et al. Validation of a chronic obstructive pulmonary disease screening questionnaire for population surveys. Respir Med. 2004;98:78–83
  32. Barr R, Herbstman J, Speizer F, et al. Validation of a self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol. 2002;155:965–971
  33. Price DB, Tinkelman DG, Halbert RJ, et al. Symptom-based questionnaire for identifying COPD in smokers. Respiration. 2006;73:285–295
  34. Kida K, Wakabayashi R, Mizuuchi T, et al. Screening for suspected chronic obstructive pulmonary disease with an eleven-item pre-interview questionnaire (11-Q). doi:10.2169/internalmedicine.45.1694.
  35. Freeman D, Nordyke RJ, Isonaka S, et al. Questions for COPD diagnostic screening in a primary care setting. Respir Med. 2005;99:1311–1318

PII: S0954-6111(10)00076-4

doi: 10.1016/j.rmed.2010.02.009

Respiratory Medicine
Volume 104, Issue 8 , Pages 1160-1170 , August 2010

Article Tools

* Image Usage & Resolution